Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. New study on SCT therapy for SAA, MDS patients

    ... and hypoplastic MDS is characterized by decreased marrow cellularity . Cordin is a variety of stem cell transplantation that uses ...

    Article last updated 08/22/2017 - 9:41am.

  2. Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience

    ... (i.e. with/without G-CSF or eltrombopag). While marrow cellularity did not correlate with peripheral-blood counts at 3 months, ...

    Research Article last updated 09/13/2017 - 7:40am.

  3. Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher-risk myelodysplastic syndromes

    ... hoc AZA-001 trial analysis assessed whether baseline BM cellularity affected the overall survival (OS) advantage demonstrated with ... care regimens (CCR). Baseline BM biopsies of <30% cellularity were considered hypocellular with data evaluable from 299 patients ...

    Research Article last updated 02/04/2014 - 1:32pm.

  4. Study of aplastic anemia med shows significant results

    ... a nonhematologic cause. Marked increases in bone marrow cellularity , CD34+ cell number, and frequency of early hematopoietic ...

    Article last updated 04/24/2017 - 7:14am.

  5. Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)

    ... Although most MDS patients have normal or increased BM cellularity (NH-MDS), some have hypocellular BM (h-MDS). The ...

    Research Article last updated 09/19/2016 - 11:07am.

  6. Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) (CHAMP)

    ... assessments, defined as: Bone marrow cellularity < 25% or marrow cellularity < 50% but with < 30% residual hematopoietic cells. Two out of ...

    Clinical Trial last updated 05/22/2017 - 11:00am.

  7. My Son, the Athlete and Survivor

    ... they ran more tests and did more marrow biopsies. The cellularity was spotty at 10-40% but nothing else in the bloodwork stood ...

    Patient Chronicle last updated 12/14/2016 - 1:53pm.

  8. A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.

    ... were cytoreduced according to pre-defined criteria ( cellularity <20% and blasts <10%). Marrow cellularity (P<0.0001) and blast% (P=0.03) were reduced. Toxicities were ...

    Research Article last updated 06/28/2013 - 1:30pm.

  9. Unveiling the paradoxical nature of myelodysplastic syndromes (MDS): Why hypercellular marrow strongly favors accelerated apoptosis.

    ... peripheral blood cytopenias and increased bone marrow cellularity . This apparent paradox has been interpreted as a sign of ...

    Research Article last updated 09/26/2013 - 3:13pm.

  10. High levels of vascular endothelial growth factor protein expression are associated with an increased risk of transfusion dependence in myelodysplastic syndromes

    ... (MDS). VEGF levels normalized for bone marrow cellularity (VEGF index [VEGFi]) were higher in the World Health ...

    Research Article last updated 03/05/2013 - 9:11am.